Log In
Print this Print this


Also known as: travoprost

  Manage Alerts
Collapse Summary General Information
Company Novartis AG
DescriptionModified steroid to inhibit neovascularization in the eye
Molecular Target Not available
Mechanism of ActionNA
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentMarketed
Standard Indication Ophthalmic (unspecified)
Indication DetailsReduce elevated intraocular pressure (IOP) in patients with open-angle glaucoma or ocular hypertension
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today